Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT06668766 · ClinicalTrials.gov registry record · NA

Single Lumen Midline Catheter vs Long Peripheral Intravenous Cather for Difficult Intravenous Access in the ED

A NA study of Emergency Department Patient and Midline Catheter, sponsored by Albany Medical College.

Recruiting
Registry status
NA
Development phase
270
Enrollment target
1
Study location

NCT06668766 is a NA study of Emergency Department Patient and Midline Catheter that is actively recruiting participants, run by Albany Medical College. The registered enrollment target is 270 participants, roughly in line with the 293-participant average among 5 other Emergency Department Patient trials with a reported enrollment target. The trial reports 1 study location across 1 state.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT06668766, a NA study of Emergency Department Patient and Midline Catheter, is actively recruiting participants, sponsored by Albany Medical College.

RECRUITING
Registry status
NA
Development phase
270 participants
Enrollment target
1
Study location

Study Summary

Many patients in the emergency department have veins that are difficult to get an intrevenous (IV) catheter into (called "difficult IV access"). These patients may require other methods to obtain access to a vein for administration of the necessary medications. The 2-inch long IV is most commonly used in emergency departments for people with difficulty IV access. Typically, a healthcare worker will use an ultrasound to help to see the veins underneath the skin while inserting the IV into the vein. That is, the ultrasound helps the healthcare worker visualize veins that are deeper in the arm and may not be felt through the skin. Another device that can be used is a 4-inch midline catheter. This device is less commonly used as many emergency departments do not have participants available, but it serves the same purpose as the 2-inch long IVs (that is, to give medicine into the vein and sometimes to take blood). A 4-inch midline catheter is similar to a 2-inch long IV, but has a few differences. First, the 4-inch midline catheter is even longer than the 2-inch long IV. The 4-inch midline catheter is 10-cm (about 4-inches or the size of 4 quarters side-by-side), while the 2-inch long IV is 4.78-cm (nearly 2-inches or two quarters side-by-side). Second, the 4-inch midline catheter is inserted into using a guidewire to help move the catheter in the vein (similar in concept to a train moving along a track), while the 2-inch long IV does not have this guidewire. The guidewire does not hurt and most do not know it is being used. It is just an additional step to help guide the catheter in the vein. The investigators are conducting this research study to determine which catheter is better for patients with difficult IV access: the 4-inch midline catheter or the 2-inch long IV.

Interventions

  • DEVICE 10-cm Single Lumen Mildine
  • DEVICE 4.78 cm Long Peripheral Intravenous Catheter

Study Locations (1)

New York

  • Albany Medical Center Hospital - Albany

Trial Details

FieldValue
Enrollment Target 270 participants
Start Date 2025-01-01
Est. Completion 2027-10-21
Phase NA

Sponsor

Albany Medical College

52 total trials

What the Registry Record Tells You About NCT06668766

The ClinicalTrials.gov registry entry for NCT06668766 describes a study currently listed as recruiting, categorized as NA. The registered enrollment target is 270 participants, a figure that helps gauge the scale of data the investigators plan to collect, roughly in line with the 293-participant average among 5 other Emergency Department Patient trials with a reported enrollment target. The listed sponsor is Albany Medical College, which has 52 total studies on file at ClinicalTrials.gov.

The record links to 4 conditions, with Emergency Department Patient appearing as the primary indexed condition, and to 2 interventions - of which 10-cm Single Lumen Mildine is the first listed.

NCT06668766 reports 1 study location spanning 1 distinct geographic area - top geographies include New York.

Frequently Asked Questions

What is clinical trial NCT06668766 about?

NCT06668766 is a clinical study titled "Single Lumen Midline Catheter vs Long Peripheral Intravenous Cather for Difficult Intravenous Access in the ED". Many patients in the emergency department have veins that are difficult to get an intrevenous (IV) catheter into (called "difficult IV access"). These patients may require other methods to obtain access to a vein for administration of the necessary medications. The 2-inch long IV is most commonly us...

What is the current status of trial NCT06668766?

This trial is currently recruiting. It is a NA study. The enrollment target is 270 participants. The study started on 2025-01-01. Estimated completion is 2027-10-21.

What conditions does trial NCT06668766 study?

This clinical trial studies the following conditions: Emergency Department Patient, Midline Catheter, Difficult Intravenous Access, Peripheral Intravenous Catheter.

What interventions are being tested in trial NCT06668766?

The interventions under investigation include: 10-cm Single Lumen Mildine (DEVICE), 4.78 cm Long Peripheral Intravenous Catheter (DEVICE).

Who is sponsoring clinical trial NCT06668766?

This trial is sponsored by Albany Medical College, which has 52 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT06668766 being conducted?

This trial has 1 study location across New York. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Emergency Department Patient

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.